We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

6526:TSESocionext Inc. Analysis

Data as of 2026-03-15 - not real-time

NT$533.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Airoha Technology Corp. is trading well above its short‑term, medium‑term and long‑term moving averages, indicating bullish positioning. The relative strength index sits near the upper half of its neutral zone, suggesting momentum remains on the upside without being overbought. MACD shows a bullish crossover with the line above the signal and a positive histogram, reinforcing technical strength. Volume trends are increasing, and the stock is holding above a strong support level while facing resistance near the upper end of its recent range, giving a clear trading corridor. Volatility is elevated, implying price swings can be sizable, while beta close to one points to market‑aligned risk.
On the fundamentals side, the forward price‑to‑earnings multiple is well below the industry average, indicating relative cheapness on a forward basis. However, the discounted cash‑flow model values the company at roughly half of the current price, flagging a potential overvaluation. The company delivers a solid dividend yield in the low‑single‑digit range with a payout ratio near three‑quarters, supported by ample cash reserves and modest debt. Earnings per share are projected to rise sharply, yet revenue is contracting at a mid‑single‑digit annual decline, tempering growth optimism. Overall, the blend of bullish technicals, attractive dividend and forward valuation contrasts with a high DCF gap and revenue weakness, suggesting a nuanced investment case.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish technical indicators (price above moving averages, MACD crossover)
  • Increasing volume supporting upward momentum
  • Support level provides downside buffer

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Forward PE advantage versus industry
  • Attractive dividend yield and payout sustainability
  • Projected EPS growth offsetting revenue decline

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • DCF valuation indicates substantial overpricing
  • Revenue contraction raises growth concerns
  • High volatility and sector cyclicality

Key Metrics & Analysis

Financial Health

Revenue Growth-5.80%
Profit Margin13.86%
P/E Ratio30.8
ROE13.25%
ROA6.57%
Debt/Equity1.03
P/B Ratio4.6
Op. Cash FlowNT$4.1B
Free Cash FlowNT$1.9B
Industry P/E33.7

Technical Analysis

TrendNeutral
RSI60.1
SupportNT$431.00
ResistanceNT$582.00
MA 20NT$490.93
MA 50NT$461.10
MA 200NT$501.35
MACDBullish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Fair ValueNT$231.42
Target PriceNT$605.00
Upside/Downside13.51%
GradeOvervalued
TypeBlend
Dividend Yield2.35%

Risk Assessment

Beta0.90
Volatility66.60%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.